EB1 induces cell proliferation through the activation of beta-catenin/Tcell factor pathway [9, 21], and the activation of aurora-B [34], a kinase essential for mitosis in breast cancer for which EB1 negatively impacts survival [8]. Here, MAPRE2 is linked to breast carcinoma.